Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.
Mar 11, 2021
0
4
A naturally occurring antibody capable of stimulating the body's immune-suppressing regulatory T cells has been discovered by a team of Harvard scientists, a finding that may eventually open a new door into kinder, gentler ...
In parts of Africa, where the rate of HIV is high, researchers found that using mobile vans to dispense antiretroviral treatment and other care greatly increased viral suppression.
Mar 9, 2020
0
1
A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most ...
Mar 9, 2020
0
35
The body's immune response to fungal infections changes when a patient is also infected by a virus, according to new research which investigated the two types of infection together for the first time.
Feb 27, 2020
1
332
Adding maraviroc to standard combined antiretroviral therapy (c-ART) does not seem to improve clinical outcomes for patients initiating treatment for advanced HIV infection. Findings from a double-blind randomized controlled ...
Feb 11, 2020
0
2
New research led by the University of Sheffield has discovered how a hospital superbug evades the immune system to cause infection – paving the way for new treatments.
May 2, 2019
0
9
Fungus can imitate signals from our immune system and prevent our body from responding to infection, new research from the University of Sheffield has found.
Mar 28, 2019
0
346
A pillar of the federal government's plans to fight the HIV epidemic is PrEP: pre-exposure prophylaxis. For someone who is HIV-negative but at risk of becoming infected, this means taking anti-retroviral drugs before possible ...
Mar 8, 2019
0
1
Among people with HIV in Latin America, those diagnosed with tuberculosis (TB) at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB, according to findings ...
Mar 7, 2019
0
0
